www.coe.int/Pompidou
Pompidou Group – DG1 Open Day 19.05.2014
The Pompidou Group:
Its role and activities
The European Framework
DG I – ISAC Information Society
and Action Against Crime
Pompidou Group
Set up in 1971
Incorporated...
(Co-operation Group to Combat Drug Abuse and Illicit Trafficking
in Drugs)
• intergovernmental body set up in 1971 at the ...
• mission: contribute to the development of multidisciplinary,
innovative, effective and “evidence-based” drug policies in...
• Secretariat in DGI Human Rights and Rule of Law of Council of Europe, Strasbourg
• Ministerial Conference (held every 4 ...
The European Drug Prevention Prize
6
Created in 2004 to recognise the importance and protective
factor of active youth par...
Human rights in drug policy
Aim: promote human rights and bringing them to the forefront of drug
policies as stipulated in...
Aim: development and implementation of coherent policies for psychoactive
substances
• This research work has evolved and ...
Airports: Customs and law enforcement officers from 36 countries and Japan, Mexico, USA, international
organisations, In 2...
• The Pompidou Group is perceived as a pioneer in Europe regarding the integration of the gender
aspect in drug policies. ...
MedNET set up in 2006 after start of cooperation in 1999
Aim: promote cooperation, and two-way transfer of
knowledge betwe...
Contribution to human rights and public health through support
to the introduction of opiate substitution treatment in the...
• Support to members States for developing, implementing and reviewing national drug
policicies resulted in development of...
Cooperation with
international organisations
UNODC
Regional
Offices
INCB WHO-HIPP
EMCDDA
European
Union
Pompidou
Group
In ...
Response to a crisis
Support to opiate substitution treatment in Ukraine: development of an emergency plan
In response to ...
For further information, please visit our website
http://www.coe.int//pompidou/
Or contact our Secretariat directly
Pompid...
Thank you for your attention!
florence.mabileau@coe.int – www.coe.int/Pompidou
17
of 17

Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou Group)

Published on: Mar 4, 2016
Published in: Government & Nonprofit      Health & Medicine      
Source: www.slideshare.net


Transcripts - Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou Group)

  • 1. www.coe.int/Pompidou Pompidou Group – DG1 Open Day 19.05.2014 The Pompidou Group: Its role and activities
  • 2. The European Framework DG I – ISAC Information Society and Action Against Crime Pompidou Group Set up in 1971 Incorporated into CoE in 1980 Council of Europe European Union European Commission DG - Justice, Freedom and security • EU Drugs Strategy 2013-2020 EMCDDA Set up in 1993 Based in Lisbon Role = provide an overview of European drug problems 2 Next Meetings: 74th Meeting of the Permanent Correspondents: 3-4 June, 2014 16th Ministerial Conference: 9-20 November, 2014 MoU between Pompidou Group and EMCDDA, November 2010
  • 3. (Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs) • intergovernmental body set up in 1971 at the suggestion of the French President Georges Pompidou. • informal co-operation forum of 7 European countries (France, Belgium, Germany, Italy, Luxembourg, Netherlands, United Kingdom) to share their experience with combating drug abuse and drug trafficking. • Enlarged partial agreement of the Council of Europe in 1980. • Co-operation is extending. In 2014, 36 member states. • Most recent : Israel, Morocco, Serbia. Mexico as observer 3 The Pompidou Group
  • 4. • mission: contribute to the development of multidisciplinary, innovative, effective and “evidence-based” drug policies in 36 member states. • seeks to link policy, practice and science. • provides a multidisciplinary forum at the wider European level where policy-makers, professionals and researchers exchange information and ideas on drug misuse and trafficking problems. • plays a bridging role with the Eastern European (Network Drug Policy cooperation in South Eastern Europe) and Mediterranean neighbourhood (MedNET) and with countries outside Europe : Japan, Mexico, USA (airport Group) China and India (precursors network). • cooperates to CoE initiatives on eg internet gouvernance and South Programme placing special emphasis on respect of human rights. 4 The Role of the Pompidou Group Practice Science Policy
  • 5. • Secretariat in DGI Human Rights and Rule of Law of Council of Europe, Strasbourg • Ministerial Conference (held every 4 years) -> adopts work programme • Permanent Correspondents = representatives of the 36 member states; senior officials in ministries in charge of drug issues (held biannually) • 2011-2014 work programme: 25 activities out of which 14 ad hoc activities to reply to the emerging needs. Here are some demand reduction and supply reduction activities. • European drug Prevention Prize • Human rights in drug policy • Research, Policy and Practice • Drug Supply reduction • Gender in drug policy • Cooperation in the Mediterranean Region MedNET • Support to national drug policies 5 The Pompidou Group’s Structure
  • 6. The European Drug Prevention Prize 6 Created in 2004 to recognise the importance and protective factor of active youth participation in the development of drug prevention projects •Every 2 years, 3 drug prevention projects led by youth for youth are rewarded, •A jury of 7 young people assess the projects. The Prize will be awarded at the 16th Ministerial Conference of the Pompidou Group in November 2014. Each winning project will receive a trophy, a certificate and €5,000. It is open to the 47 CoE countries and to MedNET countries. In 2012 : the winners were projects from Germany, Lebanon, and Spain,
  • 7. Human rights in drug policy Aim: promote human rights and bringing them to the forefront of drug policies as stipulated in the PG Declaration of Ministers in 2010 • Long perceived as an offense or deviant behaviour, drug addiction is now acknowledged as a medical condition. As such, access to appropriate treatment for those who suffer from addictive behaviour is no privilege, it is a right. The right to equitable access to health care services derives from the fundamental right to health which is enshrined in international law and especially in the European Human Rights Convention. • The 2013 PG Athens Declaration on protecting public health by ensuring essential services in drug policy austerity budgets reminds governmental and non- governmental stakeholders to remain vigilant as to the observation of human rights of people affected by drug use irrespective of budgetary constraints imposed as a result of the economic crisis. 7
  • 8. Aim: development and implementation of coherent policies for psychoactive substances • This research work has evolved and is reflected in 3 publications : • From a policy on illegal drugs to a policy on psychoactive subtances 2008 • Towards an integrated policy on psychoactive substances 2010 • Reflections on the concept of coherency for a policy on psychoactive substances and beyond 2012 • recent work focused on “what models could be used to test the coherence of a drug policy” Coherence policy markers for psychoactive substances were designed and tested among 8 countries. Publication at the 2014 Ministerial Conference, it should be a tool for policy makers to devise effective and cost efficient drug policy. Social drug research is promoted through the funding of ESSD (European Society for Social Drug Research) annual book) which provides policy makers with insights into policy development, research and patterns of drug use. 8 Policy, practice,Research
  • 9. Airports: Customs and law enforcement officers from 36 countries and Japan, Mexico, USA, international organisations, In 2014 extension to MedNET : Algeria, Morocco, Tunisia, Jordan, Egypt, Lebanon Aim: Harmonise tools to improve drug detection in airports, and enhance inter-airport cooperation. • Annual reviews of the development of drug seizures at airports • Promote the undertaking of multilateral drug seizure operational activities • Regular updates of contacts, crime figures, and the Passenger Control Handbook Precursors: Customs and law enforcement officers, public prosecutors and private sector from 36 countries and China and India Aim: Prevent licit and illicit drug precursors’ diversion towards the manufacture of illegal substances. • 13-14 October, 2011: conference on new threats arising in the field of precursor diversion. (Closing the gaps in the judicial chain from the identification of suspect assignments and backtracking to prosecution and sanction). • 13-15 November 2013 annual meeting of the precursor network • 24-26 September 2014 annual meeting of the precursor network 9 Drug Supply Reduction
  • 10. • The Pompidou Group is perceived as a pioneer in Europe regarding the integration of the gender aspect in drug policies. A number of conferences were held in the 1990’s. • As contribution to the Council of Europe Programme for Gender Equality, the Pompidou Group nominated a gender rapporteur to incorporate gender dimension into its work. • In 2013, Italy took the initiative to fund a gender specific project : the gender Dimension of Non- Medical Use of Prescription drugs project. • The study relies on trends observed in the USA. • An online survey has just been launched in around 20 countries. It aims to explore gender differences in NMUPD in Europe and in the Mediterranean Region through a documentation of data available . The survey should allow to identify gaps available, make recommendations for further research and possibly recommendations for policy development and practice. • The report will be presented at a conference in September 2014 in Rome. 10 Gender in drug policy
  • 11. MedNET set up in 2006 after start of cooperation in 1999 Aim: promote cooperation, and two-way transfer of knowledge between countries of both rims of the Mediterranean (North South and South-North exchanges) as well as within countries of the Mediterranean (South-South exchanges). Objective : improve the quality of drug policy and their implementation in all participating countries, emphasising a greater awareness of cultural factors . 12 countries : Algeria, Cyprus, Egypt, France, Greece, Italy, Jordan, Lebanon, Malta, Morocco, Portugal, Tunisia Budget of voluntary contributions, Annual activity report. Tailored made work programme replying to the country needs. Participates in the South Programme, funded by the EU and implemented by the Council of Europe Cooperation in the Mediterranean region 11
  • 12. Contribution to human rights and public health through support to the introduction of opiate substitution treatment in the region Sustainability of training of Medical staff in addictology Adaptation of a school survey methodology (MedSPAD) to the region and use of it by more and more countries Prevention projects are implemented in the region Participation of Mediterranean countries in gender projects Mediterranean countries are joining PG countries in law enforcement projects (airport group) Round tables on development of national drug policy in Morocco, Tunisia and Egypt resulted in revision of drug law and national Drug observatories are being developed South-South cooperation Cooperation goes beyond MedNET countries with study visits MedNET achievements 12
  • 13. • Support to members States for developing, implementing and reviewing national drug policicies resulted in development of national strategies in Montenegro, Moldova, Georgia, Ukraine. • Creation of a network on drug policy cooperation in South East Europe • Multi-country project on drugs in prisons was conducted in Moldova, Romania,Serbia and Ukraine with the objective of improving health in penitentiaries with respect for human rights. Injecting drug users are exposed to overdosing, infections and transmission of blood-borne diseases such as Hepatitis C or HIV. • Limiting the spread of communicable diseases in prisons thus benefits both prisoners and society as a whole and reduces the burdens on a country's health system. The project aims to develop strategies of drug treatment and social re-insertion of drug using detainees in order to reduce relapse and recidivism. The programme comprises a strong element of cooperation between the countries involved and aims at extending best practice throughout Europe as a whole. Support to drug policy 13
  • 14. Cooperation with international organisations UNODC Regional Offices INCB WHO-HIPP EMCDDA European Union Pompidou Group In the North African and Middle East regions. Participation in the commission on narcotic drugs (CND). Cooperation on backtracking precursor diversion. Joined Steering Group on Health in Prisons Programme to contribute to the drugs in prisons program Memorandum of Understanding in 2010 Participation in the South Programme Aim: to avoid overlaps and to increase synergies.
  • 15. Response to a crisis Support to opiate substitution treatment in Ukraine: development of an emergency plan In response to the humanitarian crisis in Ukraine a mission of experts representing Norway, Poland, Switzerland, and Slovenia will travel to Ukraine on 16-21 May in order to assess the situation concerning Opiate substitution treatment and to develop an emergency plan. The mission is organised by the Pompidou Group together with the Ukrainian Drug Control Service in conjunction with local and international partners. The expert mission will assess the needs for Methadone supply in dispensaries, clinics and pharmacies that may receive more clients due to the closure of Methadone dispensaries in Crimea. The experts will also conduct information seminars for physicians and therapists providing Methadone treatment based on international guidelines. Furthermore, the team will share information about best practices and emergency guidelines in case that the provision of medicines included under the WHO list of Essential Medicines such as Methadone and HIV medicines is interrupted. Pharmacists and doctors from Crimea and Eastern Ukraine, who cannot attend trainings will also be contacted and advised regarding the emergency measures in place. 15
  • 16. For further information, please visit our website http://www.coe.int//pompidou/ Or contact our Secretariat directly Pompidou Group Council of Europe F - 67075 Strasbourg - CEDEX pompidou.group@coe.int 16
  • 17. Thank you for your attention! florence.mabileau@coe.int – www.coe.int/Pompidou 17

Related Documents